The safety of calcitriol 3 μg/g ointment. Evaluation of cutaneous contact sensitization, cumulative irritancy, photoallergic contact sensitization and phototoxicity

European Journal of Dermatology

Volumn 11, Issue 3, 2001, Pages 219-224

  Queille Roussel, Catherine ^a   Duteil, Luc ^a   Parneix Spake, Anne ^b   Arsonnaud, Stephanie ^c   Rizova, Elena ^c  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^b Aster   (France)

^c Galderma R and D   (France)

Author keywords

Calcitriol 3 g g ointment; Irritancy; Photoallergic; Phototoxicity; Sensitization

Indexed keywords

CALCIPOTRIOL; CALCITRIOL; TACALCITOL; WHITE PETROLATUM;

ARTICLE; CLINICAL TRIAL; CONTACT SENSITIZATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG EFFECT; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; OINTMENT; PHOTOALLERGY; PHOTOTOXICITY; PSORIASIS; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SKIN IRRITATION;

EID: 0035017753     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. 3 in nuclear and cytosol fractions of whole mouse skin in vivo and in vitro. FEBS Lett 1981; 134: 203.
2. 2. Colston K, Hirt M, Feldman D. Organ distribution of the cytoplasmic 1,25-dihydroxycholecaciferol receptor in various mouse tissues. Endocrinology 1980; 105: 1916.
3. 3. Stumpf WE, Sar M, Reid FA, et al. Target cell for 1,25-dihydroxyvitamin D in intestinal tract, stomach, kidney, skin, pituitary and parathyroid. Science 1979; 206: 1188-90.
4. 4. Tanaka H, Abe E, Miyaura C, et al. 1α, 25-dihydroxycholecalciferol and a human myeloid leukemia cell line (UL-60). The presence of a cytosol receptor and induction of differentiation. J Biochem 1982; 240: 713-9.
5. 5. Lea AP, Goa KL. Calcipotriol: a review of its pharmacological properties and therapeutic efficocy in the management of psoriasis. Clin Immunother 1996; 5: 230-48.
6. 6. Fullerton A, Benfeldt E, Roed Petersen J, et al. The calcipotriol dose-irritation relationship: 48 hr occlusive testing in healthy volunteers using Finn Chambers. Br J Dermatol 1998; 138: 259-65.
7. 7. Frosch PJ, Rustemeyer T. Contact allergy to calcipotriol does exist. Contact Dermatitis 1999; 40: 66-71.
8. 8. Peters DC, Balfour JA. Tacalcitol. Drugs 1997; 54: 265-71.
9. 9. Van de Kerkhof PCM, Werfel T, Haustein UF, et al. Tacalcitol ointment in the treatment of psoriasis vulgaris: a multicentre, placebo-controlled, double-blind study on efficacy and safety. Br J Dermatol 1996; 135: 758-65.
10. 10. Even-Paz Z, Efron D, Kudish A. Optimised heliotherapy for psoriasis. Br J Dermatol 1999; 141: 957-68.
11. 11. De Rie MA, Di Nuzzo S, Hansen AB, et al. Calcipotriol cream or ointment applied immediately before irradiation inhibits UVB erythema. Br J Dermatol 1999; 141: 957-68.
12. 3 white petrolatum ointment in psoriasis. A randomized, double-blind, left-right, vehicle-controlled study of twice daily application of 3 μg/g 1,25-(OH)2 D3 in white petrolatum ointment in chronic plaque psoriasis. Solvay Duphar study number H. 141.5006/A, Report, 1991.
13. 3) treatment of psoriasis: an immunohistological evaluation. Acta Dern Venerol (Stockh) 1997; 77: 268-72.
14. 14. Langner A, Verjans H, Stapor V, et al. Topical calcitriol in the treatment of chronic plaque psoriasis: a double-blind study. Br J Dermatol 1993; 128: 566-71.
15. 3 (calcitriol) ointment in psoriasis. J Dermatol Treat 1992; 3: 177-80.
16. 16. Langner A, Ashton P, Van de Kerkhof PCM, et al. A long-term multicentre assessment of the safety and tolerability of calcitriol ointment in the treatment of chronic plaque psoriasis. Br J Dermatol 1996: 135: 385-9.
17. 17. Hutchinson PE, Marks R, White J. The efficacy, safety and tolerance of calcitriol 3 μg/g ointment in the treatment of chronic plaque psoriasis: a comparison with dithranol. Dermatology 2000: 201: 139-45.
18. 18. Ring J, Kowalzick I, Christophers E, et al. Comparison of combined calcitriol 3 μg/g ointment and UVB photography with vehicle ointment and UVB phototherapy in the treatment of plaque psoriasis. Paper submitted for publication and posters.
19. 3) for treatinq psoriasis in children. Arch Dermatol 1995; 131: 961-2.
20. 3 metabolites and analogues in the treatment of scalp psoriasis J Dermatol Treat 9 (suppl. 3): 41-5.
21. 21. Bourke JF, Iqbal SJ, Hutchinson PE. A randomized double-blind comparison of the effects on systemic calcium homeostasis of topical calcitriol (3 micrograms/g) and calcipotriol (50 micrograms/g) in the treatment of chronic plaque psoriasis vulgaris. Acta Derm Venereol 1997; 77: 228-30.